The Strategic Advisory Group of Experts on Immunization (SAGE) will hold a virtual press conference to brief the journalists of the outcome of their biannual meeting that took place from 5 to 7 October.
During the meeting, SAGE discussed critical topics relating to immunization globally. Agenda items included:
Impact of the COVID-19 pandemic on immunization activities
Updated evidence on efficacy, effectiveness and safety of rotavirus vaccines
Polio eradication and novel oral polio vaccine type 2 (nOPV2) development
COVID-19 vaccine priority populations
Pneumococcal Vaccines: considerations for use in older adults and use in outbreak settings
WHEN: Friday, 9 October at 12:30 CEST (Central European Summer Time)
Dr Alejandro Cravioto, Chair, Strategic Advisory Group of Experts (SAGE) on Immunization
Dr Joachim Hombach, Executive Secretary SAGE, WHO
Dr Kate O’Brien, Director, Department of Immunization, Vaccines and Biologicals, WHO
Simona Zipursky, co-lead of the Global Polio Eradication Initiative nOPV2 Working Group, WHO
Audio recording of the press conference will be made available.
What is SAGE?
The Strategic Advisory Group of Experts (SAGE) on Immunization is the principal advisory group to WHO for vaccines and immunization. It is charged with advising WHO on overall global policies and strategies, ranging from vaccines and technology, research and development, to delivery of immunization and its linkages with other health interventions. SAGE is concerned not just with childhood vaccines and immunization, but all vaccine-preventable diseases.
You are receiving this NO-REPLY email because you are included on a WHO mail list. If you have been forwarded this update you can click here to subscribe. Journalists may send feedback toWHO Media Team
World Health Organization, Avenue Appia 20, 1202 Geneva 27, Switzerland